Harry Vrieling

Associate professor

Leiden University Medical Center

Netherlands

Research Interests

Explore related searches

Professors in Netherlands Professors in Cancer Biology Cancer Biology professors in Netherlands

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (6)

Maaike P.G. Vreeswijk

Associate Professor

Leiden University Medical Center

NETHERLANDS

View details

Anja Wilmes

University of Amsterdam

NETHERLANDS

View details

Pascaline Gaildrat

PhD, Assistant Professor (MCU)

FRANCE

View details

Christi van Asperen

Board Certification of Medical Specialists in the Netherlands, Clinical geneticist, 2021 recertification for 5 years. 2012-present Professor in Clinical Genetics, Leiden University, Leiden 2013-present Head of department Clinical Genetics, Leiden University Medical Center, Leiden, the Netherlands. Including Genetic Counseling Service and Laboratory of Diagnostic Genome Analysis (LDGA).

Leiden University Medical Center

NETHERLANDS

View details

Bharath Sampadi

Leiden University Medical Center

NETHERLANDS

View details

Judith R. Kroep

Leiden University Medical Center

NETHERLANDS

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Harry Vrieling

Research Interests

Explore related searches

Contact this professor

Articles (10)

Performance of a RAD51-based functional HRD test on paraffin-embedded breast cancer tissue

RAD51 as a functional biomarker for homologous recombination deficiency in cancer: a promising addition to the HRD toolbox?

Low and high doses of ionizing radiation evoke discrete global (phospho)proteome responses.

The RAD51-FFPE Test; Calibration of a Functional Homologous Recombination Deficiency Test on Diagnostic Endometrial and Ovarian Tumor Blocks

Phosphoproteomics Sample Preparation Impacts Biological Interpretation of Phosphorylation Signaling Outcomes.

The RECAP Test Rapidly and Reliably Identifies Homologous Recombination-Deficient Ovarian Carcinomas

Alternative mRNA splicing can attenuate the pathogenicity of presumed loss-of-function variants in BRCA2

The EU-ToxRisk method documentation, data processing and chemical testing pipeline for the regulatory use of new approach methods.

Quantitative phosphoproteomics to unravel the cellular response to chemical stressors with different modes of action

Skipping Nonsense to Maintain Function: The Paradigm of BRCA2 Exon 12.

Collaborators (6)

Maaike P.G. Vreeswijk

Anja Wilmes

Pascaline Gaildrat

Christi van Asperen

Bharath Sampadi

Judith R. Kroep

Make your next move.